Publications

Search
Author Title Type Year(Asc)
2013
Srirangan, K., Orr, V., Akawi, L., Westbrook, A., Moo-Young, M., & Chou, C. P.. (2013). Biotechnological advances on Penicillin G acylase: Pharmaceutical implications, unique expression mechanism and production strategies. Biotechnology Advances, 31, 1319-1332. 2013_biotechnological_advances_on_penicillin_g_acylase_pharmaceutical_implications_unique_expression_mechanism_and_production_strategies.pdf
Pyne, M. E., Moo-Young, M., Chung, D. A., & Chou, C. P.. (2013). Development of an electrotransformation protocol for genetic manipulation of Clostridium pasteurianum. Biotechnology for Biofuels, 6. 2013_development_of_an_electrotransformation_protocol_for_genetic_manipulation_of_clostridium_pasteurianum.pdf
Srirangan, K., Akawi, L., Liu, X. J., Westbrook, A., Blondeel, E. J. M., Aucoin, M. G., Moo-Young, M., et al. (2013). Manipulating the sleeping beauty mutase operon for the production of 1-propanol in engineered Escherichia coli. Biotechnology for Biofuels, 6. 2013_manipulating_the_sleeping_beauty_mutase_operon_for_the_production_of_1-propanol_in_engineered_escherichia_coli.pdf
Orr, V., Zhong, L. Y., Moo-Young, M., & Chou, C. P.. (2013). Recent advances in bioprocessing application of membrane chromatography. Biotechnology Advances, 31, 450-465. 2013_recent_advances_in_bioprocessing_application_of_membrane_chromatography.pdf
2012
Sukhija, K., Pyne, M., Ali, S., Orr, V., Abedi, D., Moo-Young, M., & Chou, C. P.. (2012). Developing an Extended Genomic Engineering Approach Based on Recombineering to Knock-in Heterologous Genes to Escherichia coli Genome. Molecular Biotechnology, 51, 109-118.
Srirangan, K., Akawi, L., Moo-Young, M., & Chou, C. P.. (2012). Towards sustainable production of clean energy carriers from biomass resources. Applied Energy, 100, 172-186. 2012_towards_sustainable_production_of_clean_energy_carriers_from_biomass_resources.pdf
Orr, V., Scharer, J., Moo-Young, M., Honeyman, C. H., Fenner, D., Crossley, L., Suen, S. Y., et al. (2012). Simultaneous clarification of Escherichia coli culture and purification of extracellularly produced penicillin G acylase using tangential flow filtration and anion-exchange membrane chromatography (TFF-AEMC). Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 900, 71-78.
Orr, V., Scharer, J., Moo-Young, M., Honeyman, C. H., Fenner, D., Crossley, L., Suen, S. Y., et al. (2012). Integrated development of an effective bioprocess for extracellular production of penicillin G acylase in Escherichia coli and its subsequent one-step purification. Journal of Biotechnology, 161, 19-26.
2011
Zhong, L. Y., Srirangan, K., Scharer, J., Moo-Young, M., Fenner, D., Crossley, L., Honeyman, C. H., et al. (2011). Developing an RNase-free bioprocess to produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane chromatography. Separation and Purification Technology, 83, 121-129.
Zhang, L., Chou, C. P., & Moo-Young, M.. (2011). Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system. Biotechnology Advances, 29, 923-929. 2011_disulfide_bond_formation.pdf
Zhang, L., Moo-Young, M., & Chou, C. P.. (2011). Molecular manipulation associated with disulfide bond formation to enhance the stability of recombinant therapeutic protein. Protein Expression and Purification, 75, 28-39.
Zhong, L. Y., Scharer, J., Moo-Young, M., Fenner, D., Crossley, L., Honeyman, C. H., Suen, S. Y., et al. (2011). Potential application of hydrogel-based strong anion-exchange membrane for plasmid DNA purification. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 879, 564-572.
Srirangan, K., Pyne, M. E., & Chou, C. P.. (2011). Biochemical and genetic engineering strategies to enhance hydrogen production in photosynthetic algae and cyanobacteria. Bioresource Technology, 102, 8589-8604. 2011_biochemical_and_genetic_engineering_strategies_to_enhance_hydrogen_production_in_photosynthetic_algae_and_cyanobacteria.pdf
Narayanan, N., Khan, M., & Chou, C. P.. (2011). Enhancing Functional Expression of Heterologous Burkholderia Lipase in Escherichia coli. Molecular Biotechnology, 47, 130-143.
2010
Ge, W., Arp, J., Lian, D. M., Liu, W. H., Baroja, M. L., Jiang, J. F., Ramcharran, S., et al. (2010). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation, 90, 1145-1156.
Pyne, M. E., Sukhija, K. S., & Chou, C. P.. (2010). Strain improvement of Escherichia coli to enhance recombinant protein production. In Manual of Industrial Microbiology and Biotechnology (3rd ed., pp. 273-286). ASM Press. asm_mimb3_ch19.pdf
Zhang, L., Moo-Young, M., & Chou, C. P.. (2010). Effect of aberrant disulfide bond formation on protein conformation and molecular property of recombinant therapeutics. Pure and Applied Chemistry, 82, 149-159.
Zhang, L., Narayanan, N., Brand, S. R., Nicolette, C. A., Baroja, M., Arp, J., Wang, H., et al. (2010). Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein. Protein Expression and Purification, 73, 140-146.
Narayanan, N., Khan, M., & Chou, C. P.. (2010). Enhancing functional expression of heterologous lipase B in Escherichia coli by extracellular secretion. Journal of Industrial Microbiology & Biotechnology, 37, 349-361.
2009
Xu, Y., Zhang, L., Yao, W., Yedahalli, S. S., Brand, S., Moo-Young, M., & Chou, C. P.. (2009). Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein. Protein Expression and Purification, 65, 92-99.

Pages